Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 0.01 a new company low.

Within Medical Laboratories industry Advanced Biomed Inc. booked the highest Quick Ratio than Advanced Biomed in the third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from to 14.

Explain Quick Ratio?
How much Cash & cash equivalents ADVB�s has?
What are ADVB�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADVB Quick Ratio	(Mar 31 2026) Q3	(Dec 31 2025) Q2	(Sep 30 2025) Q1	(Jun 30 2025) Q4	(Mar 31 2025) Q3
Y / Y Current Liabilities Change	-60.11 %	-27.4 %	-28.7 %	-	-
Y / Y Cash & cash equivalent Change	-99.81 %	-1.85 %	2.96 %	-	-
Quick Ratio MRQ	0.01	0.95	0.87	0.27	1.26
ADVB's Total Ranking	# 14	#	#	#	#
Seq. Current Liabilities Change	-40.08 %	-11.1 %	-70.95 %	157.71 %	9.07 %
Seq. Cash & cash equivalent Change	-99.62 %	-2.88 %	-6.41 %	-44.66 %	95.1 %

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 0
Healthcare Sector	# 1
Overall Market	# 14

Quick Ratio Statistics
High	Average	Low
1.79	0.79	0.01
(Dec 31 2025)		(Mar 31 2026)

Financial Statements
Advanced Biomed's Current Liabilities	$ 2 Millions	Visit ADVB's Balance sheet
Advanced Biomed's Cash & cash equivalent	$ 0 Millions	Visit ADVB's Balance sheet
Source of ADVB's Sales		Visit ADVB's Sales by Geography

Cumulative Advanced Biomed's Quick Ratio

ADVB's Quick Ratio for the trailling 12 Months

ADVB Quick Ratio	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months	(Mar 31 2025) 12 Months
Y / Y Current Liabilities TTM Growth	47.98 %	153.77 %	399.28 %	-	-
Y / Y Cash & cash equivalent TTM Growth	-21.79 %	153.48 %	413.63 %	-	-
Quick Ratio TTM	0.45	0.65	0.62	0.58	0.85
Total Ranking TTM	# 2060	# 1967	#	#	#
Seq. Current Liabilities TTM Growth	-12.04 %	-4.79 %	-5.44 %	86.86 %	50.84 %
Seq. Cash & cash equivalent TTM Growth	-38.77 %	-0.37 %	0.58 %	27.46 %	98.46 %

Quick ratio ranking by company, industry and sector >> Back to ADVB Financial Strength Comparisons >> Go to Compare ADVB Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in ADVB's Current Liabilities to $1.65 millions, cumulative Quick Ratio to 0.45 below the ADVB average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry ADVB achieved the highest Quick Ratio. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from to 17.

Explain Quick Ratio?
How much Cash & cash equivalents ADVB�s has?
What are ADVB�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	#
Healthcare Sector	#
Within the Market	# 14

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.67	0.57	0.47
(Dec 31 2025)		(Mar 31 2026)

Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Medical Laboratories Industry	Quick Ratio	Mar 31 2026 MRQ Cash & cash equivalent	Mar 31 2026 MRQ Current Liabilities
First Choice Healthcare Solutions Inc	0.01	$ 0.613 Millions	$ 41.825 Millions
Advanced Biomed Inc.	0.01	$ 0.010 Millions	$ 1.646 Millions
Ispecimen inc	0.00	$ 0.012 Millions	$ 5.600 Millions
Foxo Technologies Inc	0.00	$ 0.066 Millions	$ 31.563 Millions

Date modified: 2026-09-04T09:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.